Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

PolyTherics broadens collaboration with Biocompatibles International

PolyTherics : 05 March, 2008  (New Product)
PolyTherics has expanded its collaboration with Biocompatibles International, a leading medical technology company in the field of drug device combination products, to explore the biological effects on proteins of Biocompatibles’ proprietary phosphorylcholine (PC) drug delivery technology.

The new study builds on the companies’ established success in applying their respective technologies to the development of protein-based products.

PolyTherics has also granted Biocompatibles an option to develop and commercialise PC-based products utilising PolyTherics’ proprietary linker technology and intellectual property. Upon the exercise of its option and entry into a product commercialisation agreement, Biocompatibles will pay PolyTherics a royalty on net income resulting from PC-based products that utilise PolyTherics’ technology.

Dr Keith Powell, chief executive officer of PolyTherics, said: “We are very pleased to extend our collaboration with Biocompatibles, as it has already proved to be highly productive and successful. The future prospect of Biocompatibles exploiting our collaboration IP to commercialise products is an exciting step towards our shared vision of creating novel and effective biopharmaceuticals.”

Dr Peter Stratford, managing director of Biocompatibles’ Farnham Product Development Centre, commented: “PolyTherics has been able to provide valuable complementary skills to those of the team here and we look forward to continuing the projects together.”
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo